{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:56:20Z","timestamp":1793044580276,"version":"4.5.0"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024514","name":"Stem Cell Research Center, Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["74550"],"award-info":[{"award-number":["74550"]}],"id":[{"id":"10.13039\/501100024514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbrc.2026.153906","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:19:47Z","timestamp":1778023187000},"page":"153906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The potential roles of nicotinic acetylcholine receptors in the pathogenesis of multiple sclerosis: A comprehensive review"],"prefix":"10.1016","volume":"821","author":[{"given":"Narges","family":"Dastmalchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4593-4803","authenticated-orcid":false,"given":"Khalil","family":"Hajiasgharzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153906_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuroscience.2024.12.029","article-title":"A review on multiple sclerosis: unravelling the complexities of pathogenesis, progression, mechanisms and therapeutic innovations","volume":"567","author":"Rida Zainab","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrc.2026.153906_bib2","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.9564","article-title":"Role of smoking in the pathogenesis of multiple sclerosis: a review article","author":"Nishanth","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.bbrc.2026.153906_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10286-019-00605-z","article-title":"Immune and autonomic nervous system interactions in multiple sclerosis: clinical implications","volume":"29","author":"Habek","year":"2019","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.bbrc.2026.153906_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41392-025-02415-4","article-title":"Multiple sclerosis: molecular pathogenesis and therapeutic intervention","volume":"10","author":"Boutitah-Benyaich","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.153906_bib5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41573-022-00477-5","article-title":"Thinking outside the box: non-canonical targets in multiple sclerosis","volume":"21","author":"Bierhansl","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2026.153906_bib6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41573-019-0035-2","article-title":"Progressive multiple sclerosis: from pathophysiology to therapeutic strategies","volume":"18","author":"Faissner","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2026.153906_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211007687","article-title":"Inflammation in multiple sclerosis","volume":"14","author":"Haase","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.bbrc.2026.153906_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jneuroim.2016.12.004","article-title":"Innate immune regulation of autoimmunity in multiple sclerosis: focus on the role of toll-like receptor 2","volume":"304","author":"Hossain","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbrc.2026.153906_bib9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00281-019-00765-0","article-title":"Resolution of inflammation during multiple sclerosis","volume":"41","author":"Ruiz","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.bbrc.2026.153906_bib10","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.3390\/ijms22094912","article-title":"Cholinergic modulation of neuroinflammation: focus on \u03b17 nicotinic receptor","volume":"22","author":"Piovesana","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153906_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11481-010-9210-2","article-title":"Nicotinic modulation of innate immune pathways via \u03b17 nicotinic acetylcholine receptor","volume":"5","author":"Cui","year":"2010","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153906_bib12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","article-title":"Nicotinic acetylcholine receptor \u03b17 subunit is an essential regulator of inflammation","volume":"421","author":"Wang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153906_bib13","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/bjp.2008.185","article-title":"Acetylcholine beyond neurons: the non\u2010neuronal cholinergic system in humans","volume":"154","author":"Wessler","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153906_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/joim.13006","article-title":"Beyond neurotransmission: acetylcholine in immunity and inflammation","volume":"287","author":"Cox","year":"2020","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbrc.2026.153906_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/biomedicines8060153","article-title":"Possible correlation between cholinergic system alterations and neuro\/inflammation in multiple sclerosis","volume":"8","author":"Gatta","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2026.153906_bib16","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1007\/s00018-016-2175-4","article-title":"Modulatory effects of \u03b17 nAChRs on the immune system and its relevance for CNS disorders","volume":"73","author":"Kalkman","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2026.153906_bib17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.intimp.2015.06.034","article-title":"Nicotinic receptor activation negatively modulates pro-inflammatory cytokine production in multiple sclerosis patients","volume":"29","author":"Reale","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrc.2026.153906_bib18","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3390\/ijms17122009","article-title":"Dysregulated homeostasis of acetylcholine levels in immune cells of RR-Multiple sclerosis patients","volume":"17","author":"Di Bari","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153906_bib19","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41598-018-19701-7","article-title":"Butyrylcholinesterase and acetylcholinesterase polymorphisms in multiple sclerosis patients: implication in peripheral inflammation","volume":"8","author":"Reale","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153906_bib20","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.neurobiolaging.2013.04.027","article-title":"Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease","volume":"34","author":"Darreh-Shori","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbrc.2026.153906_bib21","article-title":"Modulation of acetylcholine level by donepezil hydrochloride attenuates the severity of experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis","volume":"192","author":"Sant'Anna","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.153906_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12974-021-02149-4","article-title":"Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the \u03b17 nicotinic acetylcholine receptor GAT107","volume":"18","author":"Mizrachi","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbrc.2026.153906_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413427","article-title":"Role of the cholinergic anti-inflammatory reflex in central nervous system diseases","volume":"22","author":"Ramos-Mart\u00ednez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153906_bib24","article-title":"The activation of muscarinic acetylcholine receptors protects against neuroinflammation in a mouse model through attenuating microglial inflammation","volume":"25","author":"Wang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153906_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/glia.23101","article-title":"Cholinergic signaling in myelination","volume":"65","author":"Fields","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.bbrc.2026.153906_bib26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/pharmaceutics15030728","article-title":"Recent progress in multiple sclerosis treatment using immune cells as targets","volume":"15","author":"Ma","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbrc.2026.153906_bib27","article-title":"Clinical course of multiple sclerosis, cold spring harb","volume":"8","author":"Klineova","year":"2018","journal-title":"Perspect. Med."},{"key":"10.1016\/j.bbrc.2026.153906_bib28","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pharep.2017.02.017","article-title":"Mechanism of action of three newly registered drugs for multiple sclerosis treatment","volume":"69","author":"Kasare\u0142\u0142o","year":"2017","journal-title":"Pharmacol. Reports"},{"key":"10.1016\/j.bbrc.2026.153906_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00601","article-title":"Progressive multiple sclerosis: evaluating current therapies and exploring future treatment strategies","volume":"22","author":"Albelo-Mart\u00ednez","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bbrc.2026.153906_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/npr2.70039","article-title":"Primary progressive multiple sclerosis: new therapeutic approaches","volume":"45","author":"Rajabi","year":"2025","journal-title":"Neuropsychopharmacol. Reports"},{"key":"10.1016\/j.bbrc.2026.153906_bib31","series-title":"Neuroimmune Dis.","first-page":"1","article-title":"Genetic factors in neuroimmune diseases","author":"Didonna","year":"2024"},{"key":"10.1016\/j.bbrc.2026.153906_bib32","article-title":"Lifestyle and environmental factors in multiple sclerosis, cold spring harb","volume":"9","author":"Alfredsson","year":"2019","journal-title":"Perspect. Med."},{"key":"10.1016\/j.bbrc.2026.153906_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003926","article-title":"Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and Non-HLA effects","volume":"9","author":"Patsopoulos","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbrc.2026.153906_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1626082","article-title":"Autoimmune disease: genetic susceptibility, environmental triggers, and immune dysregulation. Where can we develop therapies?","volume":"16","author":"Kumar","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153906_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","article-title":"The immunogenetics of multiple sclerosis: a comprehensive review","volume":"64","author":"Hollenbach","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbrc.2026.153906_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577061","article-title":"The role of immune regulatory molecules in multiple sclerosis","volume":"337","author":"Afshar","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbrc.2026.153906_bib37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clim.2011.03.004","article-title":"Immunopathogenesis of multiple sclerosis","volume":"142","author":"Comabella","year":"2012","journal-title":"Clin. Immunol. Ser."},{"key":"10.1016\/j.bbrc.2026.153906_bib38","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153906_bib39","series-title":"Handb. Neurochem. Mol. Neurobiol.","first-page":"355","article-title":"Experimental autoimmune encephalomyelitis","author":"Gran","year":"2008"},{"key":"10.1016\/j.bbrc.2026.153906_bib40","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2026.153906_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-026-01647-w","article-title":"Microglia-associated progression of multiple sclerosis: target identification and therapeutic engagement in human in vitro models","author":"Blenkle","year":"2026","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbrc.2026.153906_bib42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbrc.2026.153906_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/neurosci6010023","article-title":"The connection between oxidative stress, mitochondrial dysfunction, iron metabolism and microglia in multiple sclerosis: a narrative review","volume":"6","author":"Delic","year":"2025","journal-title":"NeuroSci"},{"key":"10.1016\/j.bbrc.2026.153906_bib44","series-title":"Acetylcholine - Recent Adv. New Perspect.","article-title":"Central nicotinic and muscarinic receptors in health and disease","author":"Tizabi","year":"2023"},{"key":"10.1016\/j.bbrc.2026.153906_bib45","doi-asserted-by":"crossref","first-page":"14666","DOI":"10.1002\/jcp.28220","article-title":"Alpha7 nicotinic acetylcholine receptors in lung inflammation and carcinogenesis: friends or foes?","volume":"234","author":"Hajiasgharzadeh","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbrc.2026.153906_bib46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2012.08.012","article-title":"Nicotinic acetylcholine receptors: from basic science to therapeutics","volume":"137","author":"Hurst","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2026.153906_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0079-6123(08)62094-4","article-title":"Structure and function of neuronal nicotinic acetylcholine receptors","volume":"109","author":"Lindstrom","year":"1996","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.bbrc.2026.153906_bib48","first-page":"1","article-title":"Structure of neuronal nicotinic receptors","author":"Fasoli","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.bbrc.2026.153906_bib49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2008.07.041","article-title":"Diversity of vertebrate nicotinic acetylcholine receptors","volume":"56","author":"Millar","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbrc.2026.153906_bib50","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/iub.170","article-title":"Recent advances in understanding the structure of nicotinic acetylcholine receptors","volume":"61","author":"Zouridakis","year":"2009","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbrc.2026.153906_bib51","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/10408444.2011.623150","article-title":"Nicotine: specific role in angiogenesis, proliferation and apoptosis","volume":"42","author":"Cardinale","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.bbrc.2026.153906_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03611","article-title":"The dual role of alpha7 nicotinic acetylcholine receptor in inflammation-associated gastrointestinal cancers","volume":"6","author":"Hajiasgharzadeh","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrc.2026.153906_bib53","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tips.2006.07.004","article-title":"Brain nicotinic acetylcholine receptors: native subtypes and their relevance","volume":"27","author":"Gotti","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2026.153906_bib54","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.tips.2016.03.005","article-title":"Heteromeric \u03b17\u03b22 nicotinic acetylcholine receptors in the brain","volume":"37","author":"Wu","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2026.153906_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106727","article-title":"Signaling of nicotinic acetylcholine receptors in mononuclear phagocytes","volume":"191","author":"Richter","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2026.153906_bib56","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/j.2040-4603.2014.tb00574.x","article-title":"Autonomic nervous system and immune system interactions","volume":"4","author":"Kenney","year":"2014","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbrc.2026.153906_bib57","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3390\/biom10040507","article-title":"Activation of \u03b17 nicotinic acetylcholine receptor upregulates HLA-DR and macrophage receptors: potential role in adaptive immunity and in preventing immunosuppression","volume":"10","author":"Siniavin","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2026.153906_bib58","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/bph.15412","article-title":"Anti\u2010inflammatory effects of \u03b17\u2010nicotinic ACh receptors are exerted through interactions with adenylyl cyclase\u20106","volume":"178","author":"Zhu","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153906_bib59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7150\/ijbs.16404","article-title":"The protective effect of alpha 7 nicotinic acetylcholine receptor activation on critical illness and its mechanism","volume":"13","author":"Ren","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2026.153906_bib60","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bjp.0707264","article-title":"The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation","volume":"151","author":"de Jonge","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153906_bib61","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/35013070","article-title":"Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin","volume":"405","author":"Borovikova","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.153906_bib62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/diseases9020029","article-title":"Cholinergic modulation of the immune system in neuroinflammatory diseases","volume":"9","author":"Reale","year":"2021","journal-title":"Diseases"},{"key":"10.1016\/j.bbrc.2026.153906_bib63","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.4049\/jimmunol.0902212","article-title":"Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses","volume":"183","author":"Nizri","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2026.153906_bib64","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/biomedicines13061294","article-title":"Vagus nerve stimulation regulates the Th17\/Treg balance and alleviates lung injury in acute respiratory distress syndrome by upregulating \u03b17nAChR","volume":"13","author":"Zheng","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2026.153906_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00049","article-title":"The Vagus nerve at the interface of the microbiota-gut-brain axis","volume":"12","author":"Bonaz","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbrc.2026.153906_bib66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jneuroim.2004.11.010","article-title":"Relationship between \u03b17 nAChR and apoptosis in human lymphocytes","volume":"160","author":"De Rosa","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbrc.2026.153906_bib67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2006.12.003","article-title":"The immunosuppressive effects of nicotine during human mixed lymphocyte reaction","volume":"559","author":"Takahashi","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153906_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00507","article-title":"Activation of \u03b17 nicotinic acetylcholine receptor protects against 1-Methyl-4-Phenylpyridinium-Induced astroglial apoptosis","volume":"13","author":"Hua","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbrc.2026.153906_bib69","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.npep.2018.12.003","article-title":"Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease","volume":"73","author":"Ma","year":"2019","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bbrc.2026.153906_bib70","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2026.153906_bib71","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbi.2019.12.014","article-title":"A silent agonist of \u03b17 nicotinic acetylcholine receptors modulates inflammation ex vivo and attenuates EAE","volume":"87","author":"Godin","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbrc.2026.153906_bib72","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.3390\/molecules26206139","article-title":"Neuroinflammation modulation via \u03b17 nicotinic acetylcholine receptor and its chaperone, RIC-3","volume":"26","author":"Mizrachi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.153906_bib73","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.lfs.2007.01.043","article-title":"Immunohistochemical detection of nicotinic acetylcholine receptor subunits \u03b19 and \u03b110 in rat lung isografts and allografts","volume":"80","author":"Biallas","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2026.153906_bib74","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/ijerph18031189","article-title":"Nicotinic acetylcholine receptor involvement in inflammatory bowel disease and interactions with gut microbiota","volume":"18","author":"Rueda Ruzafa","year":"2021","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.bbrc.2026.153906_bib75","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.3390\/ijms24076524","article-title":"\u03b17- and \u03b19-Containing nicotinic acetylcholine receptors in the functioning of immune system and in pain","volume":"24","author":"Shelukhina","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153906_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106801","article-title":"Small molecule ligands for \u03b19 * and \u03b17 nicotinic receptors: a survey and an update, respectively","volume":"193","author":"Giraudo","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2026.153906_bib77","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/bph.13931","article-title":"\u03b19\u2010containing nicotinic acetylcholine receptors and the modulation of pain","volume":"175","author":"Hone","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153906_bib78","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3390\/biom9120827","article-title":"Attenuation in nicotinic acetylcholine receptor \u03b19 and \u03b110 subunit double knock-out mice of experimental autoimmune encephalomyelitis","volume":"9","author":"Liu","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2026.153906_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.765541","article-title":"Interaction of \u03b19\u03b110 nicotinic receptors with peptides and proteins from animal venoms","volume":"15","author":"Tsetlin","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbrc.2026.153906_bib80","doi-asserted-by":"crossref","first-page":"8642","DOI":"10.1021\/acs.jmedchem.3c02429","article-title":"Explorations of agonist selectivity for the \u03b19* nAChR with novel substituted carbamoyl\/amido\/heteroaryl dialkylpiperazinium salts and their therapeutic implications in pain and inflammation","volume":"67","author":"Andleeb","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.153906_bib81","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1124\/mol.61.1.150","article-title":"A novel human nicotinic receptor subunit, \u03b110, that confers functionality to the \u03b19-Subunit","volume":"61","author":"Sgard","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153906_bib82","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2011.12.022","article-title":"Mediatophore regulates acetylcholine release from T cells","volume":"244","author":"Fujii","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbrc.2026.153906_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01085","article-title":"Expression and function of the cholinergic system in immune cells","volume":"8","author":"Fujii","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.153906_bib84","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.intimp.2015.04.015","article-title":"Non-neuronal cholinergic system in regulation of immune function with a focus on \u03b17 nAChRs","volume":"29","author":"Kawashima","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrc.2026.153906_bib85","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s40478-024-01864-2","article-title":"Comparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids","volume":"12","author":"Meier","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbrc.2026.153906_bib86","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2174\/1871527313666140917121132","article-title":"Cholinergic system dysfunction and neurodegenerative diseases: cause or effect?","volume":"13","author":"Tata","year":"2014","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.bbrc.2026.153906_bib87","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/1087057113493006","article-title":"OCTN cation transporters in health and disease: role as drug targets and assay development","volume":"18","author":"Pochini","year":"2013","journal-title":"SLAS Discov."},{"key":"10.1016\/j.bbrc.2026.153906_bib88","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.neuropharm.2005.10.013","article-title":"Anti-inflammatory properties of cholinergic up-regulation: a new role for acetylcholinesterase inhibitors","volume":"50","author":"Nizri","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbrc.2026.153906_bib89","doi-asserted-by":"crossref","first-page":"12656","DOI":"10.3390\/ijms131012656","article-title":"Relation between pro-inflammatory cytokines and acetylcholine levels in relapsing-remitting multiple sclerosis patients","volume":"13","author":"Reale","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153906_bib90","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41418-022-01092-y","article-title":"Cholinergic control of Th17 cell pathogenicity in experimental autoimmune encephalomyelitis","volume":"30","author":"Nechanitzky","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrc.2026.153906_bib91","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.3390\/ijms22179290","article-title":"Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis","volume":"22","author":"Walczak-Nowicka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153906_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.577912","article-title":"Cholinergic modulation of glial function during aging and chronic neuroinflammation","volume":"14","author":"Gamage","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbrc.2026.153906_bib93","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.3390\/cells11142195","article-title":"Activation of the \u03b17 nicotinic acetylcholine receptor prevents against microglial-induced inflammation and insulin resistance in hypothalamic neuronal cells","volume":"11","author":"do Amaral","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.153906_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2017.00287","article-title":"Distinctive roles for \u03b17*- and \u03b19*-Nicotinic acetylcholine receptors in inflammatory and autoimmune responses in the murine experimental autoimmune encephalomyelitis model of multiple sclerosis","volume":"11","author":"Liu","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbrc.2026.153906_bib95","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neubiorev.2020.01.024","article-title":"Disentangling the molecular mechanisms of multiple sclerosis: the contribution of twin studies","volume":"111","author":"Buscarinu","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbrc.2026.153906_bib96","doi-asserted-by":"crossref","DOI":"10.1177\/1179573519894955","article-title":"Environmental influencers, MicroRNA, and multiple sclerosis","volume":"12","author":"Mohammed","year":"2020","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.bbrc.2026.153906_bib97","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.1797","article-title":"The risk of smoking on multiple sclerosis: a meta-analysis based on 20,626 cases from case-control and cohort studies","volume":"4","author":"Zhang","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.bbrc.2026.153906_bib98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1756285611425694","article-title":"Smoking: effects on multiple sclerosis susceptibility and disease progression","volume":"5","author":"Wingerchuk","year":"2012","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.bbrc.2026.153906_bib99","article-title":"The effect of smoking on the symptoms and progression of multiple sclerosis: a review","volume":"115","author":"Shirani","year":"2010","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.bbrc.2026.153906_bib100","series-title":"Nat. Prod","first-page":"1","article-title":"Nicotine: a possible neuroprotector in brain disorders","author":"Alkadhi","year":"2025"},{"key":"10.1016\/j.bbrc.2026.153906_bib101","article-title":"The experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke components","volume":"9","author":"Gao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.153906_bib102","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1177\/1352458512471879","article-title":"Nicotine might have a protective effect in the etiology of multiple sclerosis","volume":"19","author":"Hedstr\u00f6m","year":"2013","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.bbrc.2026.153906_bib103","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1177\/1352458520958361","article-title":"Nicotinic acetylcholine receptors \u03b17 and \u03b19 modifies tobacco smoke risk for multiple sclerosis","volume":"27","author":"Briggs","year":"2021","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.bbrc.2026.153906_bib104","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1093\/brain\/awab251","article-title":"Activation of \u03b17 nicotinic acetylcholine receptor ameliorates HIV-associated neurology and neuropathology","volume":"144","author":"Zhao","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2026.153906_bib105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jns.2011.09.008","article-title":"The association between cigarette smoking and multiple sclerosis","volume":"311","author":"Jafari","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbrc.2026.153906_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14788-w","article-title":"Smoking induces DNA methylation changes in multiple sclerosis patients with exposure-response relationship","volume":"7","author":"Marabita","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153906_bib107","first-page":"1","article-title":"Impacts of environmental tobacco smoke on the onset and progression of multiple sclerosis: a systematic review","volume":"82","author":"Schlindwein","year":"2024","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.bbrc.2026.153906_bib108","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jns.2016.09.057","article-title":"Smoking increases the risk of progression in multiple sclerosis: a cohort study in Queensland, Australia","volume":"370","author":"O'Gorman","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbrc.2026.153906_bib109","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2009.122","article-title":"Smoking and disease progression in multiple sclerosis","volume":"66","author":"Healy","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbrc.2026.153906_bib110","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76556-7","article-title":"The effect of smoking on chronic inflammation, immune function and blood cell composition","volume":"10","author":"Elisia","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153906_bib111","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.actbio.2018.06.018","article-title":"Cigarette smoke increases pro-inflammatory markers and inhibits osteogenic differentiation in experimental exposure model","volume":"76","author":"Cyprus","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bbrc.2026.153906_bib112","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.3390\/molecules27123715","article-title":"Effects of smoking on inflammatory-related cytokine levels in human serum","volume":"27","author":"Wang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.153906_bib113","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1212\/WNL.0b013e3181b2a706","article-title":"Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis","volume":"73","author":"Zivadinov","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2026.153906_bib114","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5603\/PJNNS.a2020.0032","article-title":"Smoking as a risk factor of onset and relapse of multiple sclerosis \u2014 a review","volume":"54","author":"Jasielski","year":"2020","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.bbrc.2026.153906_bib115","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1177\/1352458516685169","article-title":"Smokers with MS have greater decrements in quality of life and disability than non-smokers","volume":"23","author":"Briggs","year":"2017","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.bbrc.2026.153906_bib116","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.msard.2017.07.020","article-title":"Smoking and multiple sclerosis: a systematic review and meta-analysis using the Bradford hill criteria for causation","volume":"17","author":"Degelman","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.bbrc.2026.153906_bib117","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1165\/rcmb.2003-0259OC","article-title":"Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness","volume":"30","author":"Robbins","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.153906_bib118","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1365-2362.2001.00842.x","article-title":"Effects of smoking on activation markers, fas expression and apoptosis of peripheral blood lymphocytes","volume":"31","author":"Bijl","year":"2001","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2026.153906_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2020.110326","article-title":"Inflammatory biomarker relationships with helper T cell GPR15 expression and cannabis and tobacco smoking","volume":"141","author":"Andersen","year":"2021","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.bbrc.2026.153906_bib120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/NEN.0b013e31823cc7a6","article-title":"Butyrylcholinesterase is associated with \u03b2-Amyloid plaques in the transgenic APP SWE\/PSEN1dE9 mouse model of alzheimer disease","volume":"71","author":"Darvesh","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbrc.2026.153906_bib121","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3390\/ph16081089","article-title":"Pharmacological and electroceutical targeting of the cholinergic anti-inflammatory pathway in autoimmune diseases","volume":"16","author":"Zouali","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbrc.2026.153906_bib122","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2026.153906_bib123","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/molecules27061816","article-title":"Role of cholinergic signaling in alzheimer's disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.153906_bib124","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3390\/life15071032","article-title":"Neuronal and glial \u03b17 nicotinic acetylcholine receptors: role in alzheimer's disease pathophysiology","volume":"15","author":"Rennie","year":"2025","journal-title":"Life"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26006704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26006704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:38:59Z","timestamp":1783165139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26006704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":124,"alternative-id":["S0006291X26006704"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153906","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential roles of nicotinic acetylcholine receptors in the pathogenesis of multiple sclerosis: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153906"}}